Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Clin Endocrinol (Oxf). 2024 Sep;101(3):234-242. doi: 10.1111/cen.15058. Epub 2024 Apr 12.
Paragangliomas of the urinary bladder (UBPGLs) are rare neuroendocrine tumours and pose a diagnostic and surgical challenge. It remains unclear what factors contribute to a timely presurgical diagnosis. The purpose of this study is to identify factors contributing to missing the diagnosis of UBPGLs before surgery.
DESIGN, PATIENTS AND MEASUREMENTS: A total of 73 patients from 11 centres in China, and 51 patients from 6 centres in Europe and 1 center in the United States were included. Clinical, surgical and genetic data were collected and compared in patients diagnosed before versus after surgery. Logistic regression analysis was used to identify clinical factors associated with initiation of presurgical biochemical testing.
Among all patients, only 47.6% were diagnosed before surgery. These patients were younger (34.0 vs. 54.0 years, p < .001), had larger tumours (2.9 vs. 1.8 cm, p < .001), and more had a SDHB pathogenic variant (54.7% vs. 11.9%, p < .001) than those diagnosed after surgery. Patients with presurgical diagnosis presented with more micturition spells (39.7% vs. 15.9%, p = .003), hypertension (50.0% vs. 31.7%, p = .041) and catecholamine-related symptoms (37.9% vs. 17.5%, p = .012). Multivariable logistic analysis revealed that presence of younger age (<35 years, odds ratio [OR] = 6.47, p = .013), micturition spells (OR = 6.79, p = .007), hypertension (OR = 3.98, p = .011), and sweating (OR = 41.72, p = .013) increased the probability of initiating presurgical biochemical testing.
Most patients with UBPGL are diagnosed after surgery. Young age, hypertension, micturition spells and sweating are clues in assisting to initiate early biochemical testing and thus may establish a timely presurgical diagnosis.
膀胱副神经节瘤(UBPGL)是一种罕见的神经内分泌肿瘤,对其进行诊断和手术治疗均具有挑战性。目前仍不清楚哪些因素会导致术前诊断不及时。本研究旨在确定导致 UBPGL 术前漏诊的因素。
设计、患者和测量方法:共纳入来自中国 11 个中心的 73 例患者,以及来自欧洲 6 个中心和美国 1 个中心的 51 例患者。收集并比较了术前和术后诊断患者的临床、手术和遗传数据。采用逻辑回归分析确定与术前生化检测启动相关的临床因素。
所有患者中,仅 47.6%在术前被诊断。与术后诊断的患者相比,这些患者更年轻(34.0 岁 vs. 54.0 岁,p<0.001)、肿瘤更大(2.9 厘米 vs. 1.8 厘米,p<0.001),且更可能携带 SDHB 致病性变异(54.7% vs. 11.9%,p<0.001)。术前诊断的患者更常出现排尿症状(39.7% vs. 15.9%,p=0.003)、高血压(50.0% vs. 31.7%,p=0.041)和儿茶酚胺相关症状(37.9% vs. 17.5%,p=0.012)。多变量逻辑分析显示,年龄较小(<35 岁,比值比[OR] = 6.47,p=0.013)、排尿症状(OR = 6.79,p=0.007)、高血压(OR = 3.98,p=0.011)和出汗(OR = 41.72,p=0.013)增加了启动术前生化检测的可能性。
大多数 UBPGL 患者在术后才被诊断。年轻、高血压、排尿症状和出汗是早期启动生化检测的线索,有助于建立及时的术前诊断。